|
Inspire Pharmaceuticals, Inc. Stage: Growth Date of Investment: 2007 Web Site : http://www.inspirepharm.com Stock Symbol : NASDAQ: ISPH |
 |
Inspire Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing new treatments for diseases in the ophthalmic and respiratory areas. In July 2007, Warburg Pincus invested $75 million in Inspire. Founded in 1993 and publicly traded since 2000, Inspire currently markets two ophthalmology products and is developing products for dry eye, cystic fibrosis and glaucoma.
